Megan Sutton

Megan Sutton, DNP, has a comprehensive background in clinical development, real-world evidence, and medical affairs within the pharmaceutical industry. Megan has held key leadership roles at companies such as LEXEO Therapeutics, Renovacor, Bristol Myers Squibb, and MyoKardia. Throughout their career, they have successfully developed strategies, managed budgets, and led teams, focusing on areas such as gene therapy for rare genetic cardiomyopathies and cardiovascular products. Megan has demonstrated expertise in launching and supporting innovative therapies while building strong relationships with key stakeholders.

Megan Sutton holds a Bachelor's Degree of Science in Nursing from Georgetown University, a Master's Degree of Science in Nursing from Columbia University, and a Doctor of Nursing Practice (DNP) Degree from The George Washington University. Megan also holds additional certifications as an Acute Care Nurse Practitioner and a Certified Heart Failure Nurse.